相似文献
1
The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.
Gynecol Oncol. 2017 Nov;147(2):481-487. doi: 10.1016/j.ygyno.2017.08.027. Epub 2017 Aug 31.
2
Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancer.
Gynecol Oncol. 2016 Jun;141(3):608-615. doi: 10.1016/j.ygyno.2016.03.004. Epub 2016 Mar 21.
3
MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Biomed Pharmacother. 2018 Aug;104:763-770. doi: 10.1016/j.biopha.2018.05.077. Epub 2018 May 29.
4
MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
Gene. 2016 Jul 15;586(1):48-55. doi: 10.1016/j.gene.2016.04.001. Epub 2016 Apr 2.
5
Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.
Int J Mol Sci. 2017 Feb 26;18(3):507. doi: 10.3390/ijms18030507.
6
MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
J Ovarian Res. 2015 Aug 12;8:56. doi: 10.1186/s13048-015-0186-7.
7
Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
Anticancer Res. 2015 May;35(5):2611-7.
8
MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
Cancer Lett. 2015 Jun 28;362(1):122-30. doi: 10.1016/j.canlet.2015.03.029. Epub 2015 Mar 25.
9
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Mol Cancer. 2015 Mar 11;14:57. doi: 10.1186/s12943-015-0322-4.
10
MicroRNA let-7a modifies the effect of self-renewal gene HIWI on patient survival of epithelial ovarian cancer.
Mol Carcinog. 2016 Apr;55(4):357-65. doi: 10.1002/mc.22285. Epub 2015 Jan 28.
引用本文的文献
1
The microRNA Let-7 and its exosomal form: Epigenetic regulators of gynecological cancers.
Cell Biol Toxicol. 2024 Jun 5;40(1):42. doi: 10.1007/s10565-024-09884-3.
2
Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.
Front Endocrinol (Lausanne). 2023 Aug 9;14:1162786. doi: 10.3389/fendo.2023.1162786. eCollection 2023.
3
Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects.
Cancers (Basel). 2021 Aug 5;13(16):3970. doi: 10.3390/cancers13163970.
4
SP1-induced lncRNA DANCR contributes to proliferation and invasion of ovarian cancer.
Kaohsiung J Med Sci. 2021 May;37(5):371-378. doi: 10.1002/kjm2.12316. Epub 2020 Oct 22.
5
Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.
Oncogene. 2020 Oct;39(40):6286-6299. doi: 10.1038/s41388-020-01434-5. Epub 2020 Aug 25.
6
A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles from Culture Supernatant of Human Ovarian Cancer Cell Line A2780 and Body Fluids of High-Grade Serous Carcinoma Patients.
Cancer Manag Res. 2020 Jul 24;12:6291-6301. doi: 10.2147/CMAR.S228288. eCollection 2020.
7
From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.
Int J Mol Sci. 2020 Jun 3;21(11):4007. doi: 10.3390/ijms21114007.
8
MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.
Onco Targets Ther. 2019 Jul 8;12:5311-5322. doi: 10.2147/OTT.S213231. eCollection 2019.
9
The Endometriotic Tumor Microenvironment in Ovarian Cancer.
Cancers (Basel). 2018 Aug 7;10(8):261. doi: 10.3390/cancers10080261.
10
Branched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection.
Cancer Sci. 2018 Sep;109(9):2897-2906. doi: 10.1111/cas.13725. Epub 2018 Aug 20.
本文引用的文献
1
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes.
Nat Genet. 2017 Jun;49(6):856-865. doi: 10.1038/ng.3849. Epub 2017 Apr 24.
2
Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.
Dis Markers. 2017;2017:3098542. doi: 10.1155/2017/3098542. Epub 2017 Feb 15.
3
MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
J Ovarian Res. 2017 Jan 11;10(1):1. doi: 10.1186/s13048-016-0301-4.
4
Cancer Statistics, 2017.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
5
MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A.
Gene. 2017 Mar 20;605:99-107. doi: 10.1016/j.gene.2016.12.030. Epub 2016 Dec 31.
6
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
Cancer Res. 2016 Dec 15;76(24):7194-7207. doi: 10.1158/0008-5472.CAN-16-0714. Epub 2016 Oct 14.
7
Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis.
Oncotarget. 2016 Nov 8;7(45):72672-72684. doi: 10.18632/oncotarget.12183.
8
A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
Int J Gynecol Cancer. 2017 Jan;27(1):3-10. doi: 10.1097/IGC.0000000000000846.
9
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.
PLoS One. 2016 Sep 9;11(9):e0162584. doi: 10.1371/journal.pone.0162584. eCollection 2016.
10
Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.
Hum Pathol. 2016 Oct;56:40-51. doi: 10.1016/j.humpath.2016.05.014. Epub 2016 May 31.
Zotero 插件